Sedation for terminally ill patients with cancer with uncontrollable physical distress

Journal of Palliative Medicine

Volumn 8, Issue 1, 2005, Pages 20-25

  Kohara, Hiroyuki ^a,d   Ueoka, Hiroshi ^b   Takeyama, Hiroyasu ^a   Murakami, Tomoyuki ^a   Morita, Tatsuya ^c  

^a NATIONAL SANYO HOSPITAL   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c Seirei Mikatabara Hospital   (Japan)

^d Hiroshima Palliative Care Prom Ctr   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BROMIDE; CHLORPROMAZINE; HALOPERIDOL; MIDAZOLAM; SCOPOLAMINE; SEDATIVE AGENT;

ADULT; AGED; AGITATION; ARTICLE; CANCER PATIENT; CONSCIOUSNESS; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; DISTRESS SYNDROME; DROWSINESS; DYSPNEA; FEMALE; HOSPICE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALAISE; MALE; NAUSEA; PAIN; PALLIATIVE THERAPY; RESTLESSNESS; SEDATION; SYMPTOMATOLOGY; TERMINAL DISEASE; VOMITING;

EID: 12444282712     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2005.8.20     Document Type: Article

References (22)

1. Cherny NI, Portenoy RK: Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 1994;10:31-38.
2. Billings JA, Block SD: Slow euthanasia. J Palliat Care 1996;12:21-30.
3. Enke RE: Drug-induced terminal sedation. Am J Hosp Palliat Care 1991;8:3-5.
4. Sales JP: Sedation and terminal care. Eur J Palliat Care 2001;8:97-100.
5. Fonderas J: Sedation and ethical contradiction. Eur J Palliat Care 1996;3:17-20.
6. Cowan JD, Walsh D: Terminal sedation in palliative care medicine-Definition and review of the literature. Support Care Cancer 2001;9:403-407.
7. Beel A, McClement SE, Harlos M: Palliative sedation therapy: A review of definitions and usage. Int J Palliat Nur 2002;8:190-199.
8. Chater S, Viola R, Paterson J, Jardis V: Sedation for intractable distress in the dying-survey of experts. Palliat Med 1998;12:255-269.
9. Morita T, Tsunoda J, Inoue S, Chihara S: Do hospice clinicians sedate patients intending to hasten death? J Palliat Care 1999;15:20-23.
10. Hanks GCW, Cherny N: Opioid analgesic therapy. In: Doyle D, Hanks GCW, MacDonald N (eds): Oxford Textbook of Palliative Medicine, 2nd ed. New York: Oxford Medical Publications, 1998, pp. 331-355.
11. Dundee JW, Halliday NJ, Harper KW, Brogden RN: Midazolam-A review of its pharmacological properties and therapeutic use. Drugs 1984;28:519-543.
12. Moolenaar F, Bakker S, Visser J, Huizinga T: Biopharmaceutics of rectal administration of drugs in man. IV. Comparative biopharmaceutics of diazepam after single rectal, oral, intramascular, and intravenous administration in man. Int J Pharmaceutics 1980;5:127-137.
13. Anderson F, Downing GM, Hill J: Palliative Performance Scale (PPS): A new tool. J Palliat Care 1996;12:5-11.
14. Morita T, Tsunoda J, Inoue S, Chihara S, Oka K: Communication capacity scale and agitation distress scale to measure the severity of delirium in terminally ill cancer patients: a validation study. Palliat Med 2001;15:197-206.
15. Fainsinger RL, Landman W, Hoskings M, Bruera E: Sedation for uncontrolled symptoms in a South African hospice. J Pain Symptom Manage 1998;16:145-152.
16. Stone P, Phillips C, Spruyt O, Waight C: A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat Med 1997;11:140-144.
17. Morita T, Tei Y, Inoue S: Correlation of the dose of midazolam for symptom control with administration periods: The possibility of tolerance. J Pain Symptom Manage 2003;25:369-375.
18. Gremaud G, Zulian G: Indications and limitations of intravenous and subcutaneous midazolam in palliative care center. J Pain Symptom Manage 1998;15:331-333.
19. Sykes N, Thorns A: Sedative use in the last week of life and the implications for end-of life decision making. Arch Intern Med 2003;163:341-344.
20. Fainsinger RL, Waller A, Bercovici M Bengston K, Landman W, Hosking M, Nunez-Olarte JM, deMoissac D: A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 2000;14:257-265.
21. Morita T, Tei Y, Inoue S: Impaired communication capacity and agitated delirium in the final week of terminally ill cancer patients: Prevalence and identification of research focus. J Pain Symptom Manage 2003;26:827-834.
22. Morita T, Tsuneto S, Shima Y. Proposed definitions of terminal sedation. Lancet 2001;358:335-336.